To provide insight into the normal pathway of androgen action during embryonic and postembryonic life and into the various ways that impairment of androgen action can result in disease states, a variety of experiments are planned. Anti-idiotypic antibodies to the androgen receptor will be made for the purpose of characterizing more precisely mutations that impair the androgen receptor, and studies of the individual steps in androgen action will be made in normal and mutant fibroblast strains, including investigation of the transformation of the dihydrotestosterone-androgen receptor complex (DHR-R) to the DNA-binding state, the interaction of DHT-R with the nuclear matrix, and the post receptor events in androgen action. Phenotypic differentiation of the male urogenital tract will be studied with the specific goal of determining whether the wolffian ducts virilize directly as a result of androgen action or indirectly as the result of some effect of the hormone on the testis itself. The molecular biology of 5Alpha-reductase deficiency will be investigated by attempting to develop a potent antibody to the 5Alpha-reductase enzyme, by investigating the effect of 5Alpha-reductase inhibition on the development of the male urogenital tract, and by studying how androgens act to promote spermatogenesis. Embryonic differentiation of the gonads as endocrine organs will be studied in organ culture preparations of rat and opossum gonads and in mice carrying either a single X chromosome or the sex reversal mutation. The genetic control of the aromatase reaction in peripheral tissue will be studied utilizing the henny feathering mutation in chickens as a model system for investigating normal ovarian development and extraglandular estrogen formation. Finally, we will explore androgen action at the post-receptor level, studying the nature of thyroxine and DHT interaction in the mouse submandibular gland, the unique resistance to androgen action in kidneys of certain wild-derived mouse strains, and the regulation of androgen-dependent genes in mouse L cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK003892-28
Application #
3224433
Study Section
Biochemical Endocrinology Study Section (BCE)
Project Start
1976-06-01
Project End
1991-05-31
Budget Start
1986-06-01
Budget End
1987-05-31
Support Year
28
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Schools of Medicine
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Lanzino, Marilena; Garofalo, Cecilia; Morelli, Catia et al. (2009) Insulin receptor substrate 1 modulates the transcriptional activity and the stability of androgen receptor in breast cancer cells. Breast Cancer Res Treat 115:297-306
McPhaul, Michael J (2008) Mechanisms of prostate cancer progression to androgen independence. Best Pract Res Clin Endocrinol Metab 22:373-88
Kohler, Birgit; Delezoide, Anne-Lise; Boizet-Bonhoure, Brigitte et al. (2007) Coexpression of Wilms'tumor suppressor 1 (WT1) and androgen receptor (AR) in the genital tract of human male embryos and regulation of AR promoter activity by WT1. J Mol Endocrinol 38:547-54
Pitteloud, Nelly; Meysing, Astrid; Quinton, Richard et al. (2006) Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol 254-255:60-9
Pitteloud, Nelly; Acierno Jr, James S; Meysing, Astrid U et al. (2005) Reversible kallmann syndrome, delayed puberty, and isolated anosmia occurring in a single family with a mutation in the fibroblast growth factor receptor 1 gene. J Clin Endocrinol Metab 90:1317-22
Lanzino, Marilena; De Amicis, Francesca; McPhaul, Michael J et al. (2005) Endogenous coactivator ARA70 interacts with estrogen receptor alpha (ERalpha) and modulates the functional ERalpha/androgen receptor interplay in MCF-7 cells. J Biol Chem 280:20421-30
Villegas, Jacob; McPhaul, Michael (2005) Establishment and culture of human skin fibroblasts. Curr Protoc Mol Biol Chapter 28:Unit 28.3
Pitteloud, Nelly; Villegas, Jacob; Dwyer, Andrew A et al. (2004) Acute stress masking the biochemical phenotype of partial androgen insensitivity syndrome in a patient with a novel mutation in the androgen receptor. J Clin Endocrinol Metab 89:1053-8
Unni, Emmanual; Sun, Shihua; Nan, Bicheng et al. (2004) Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence. Cancer Res 64:7156-68
Szebenyi, Gyorgyi; Morfini, Gerardo A; Babcock, Alyssa et al. (2003) Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron 40:41-52

Showing the most recent 10 out of 106 publications